<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 252 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page251.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=252">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 252 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 252</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=252"><img src="../thumb/252.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Urinary System  / Genital System - 16.5 / 17 / 17.1 / 17.1.1                   2020-04 / 215
       Contraindications: Hypophosphataem., bowel obstruct., safety in   tin.ambulat. periton.dialys.) or CCPD (Continuous cyclic peritoneal   Dosage: Swallow whole
       pregn./lactat.& pts.und. 18 yrs. not est, concom.ciprofloxac.  dialysis) freq./formulat./exchange vol./ durat.of dwell & length of   1 cap.dly.aft.breakf.
       Side-effects: Naus., vomit., upper abdom.pain, constip., diarrh.,   dialysis determin. by physic. Heat dialysis sol.to 37°C to decr. dis-  Contraindications: Orthostat.hypotens.hist., hepat.insuffic., use
       dyspeps., flatul, intestin.obstruct., ileus.  comf. & heat loss result.in incr.urea clearanc. Addit.may be incom-  in females
       Warnings and special precautions: Safety & effic.not est.in GI   pat.theref.consult physic. 1 000-2 000 USP units hepar.may be add.  Side effects: Hypersens.reacts., angio-oed., CNS effs., depress.,
       disords.eg.dysphag./swallow. disords./ sev.GI motility disords./maj.  per litre sol.to prev.cathet.block.  hallucinat., post.hypotens., palpitat., syncope, rhinit., chest pain,
       GI surg.hist., re-eval.treatm.in pts develop.constip./sev.GI sympts,   IPD: Ac.ren.fail.& dialys.maint.of chron.ren.fail. The cycle of instillat.  dyspn., nas.congest, epistax., GI disturbs., abnorm. ejaculat., impot.,
       poss.vit A,D,E & K supplement.in pts not tak.supplement. vits, pts.to   dwell & remov.of dialysis fluid rep.sequentially over 8-36 hrs.as many   priapism, vertigo, tinnit., redden.sclera, blurr.vis., abnorm.liv.enzyme
       adhere to precrib. diets., monit.TSH lev.with concom.levothyroxine,   times/ wk. as determin.by pt.condit.  values, pancreatit., urin.freq., incontin., arthral., diaphores., asthen.
       when a reduc.bioavailabil.of a med.prod.could have a signific. clinic.  Chron.ren.fail.maint.dialys.: Period.dialys.of 3-5 session /wk.for   Special precautions: Thorough examin.bef. init. ther.to excl.other
       eff.admin.it 1 hr bef./3 hrs. aft.or monit.bld. lev. of the med, concom.  8-14 hrs./session.  condit.caus.same sympt., determ. PSA bef.& reg.aft.
       anti-arrhythm.& anti-seiz.meds.  CAPD: Maint.dialysis.of chron.ren.fail.as prescrib.  Drug interactions: Diclofen.& warfar.may incr. eliminat.rate, hypo-
       Drug interactions: Ciprofloxacin bioavail.decr., incr.TSH lev.with   Contraindications: Safety in pregn.& lactat.not est., peritonit., ex-  tens.effs.with concom.other alpha 1-adrenocept.antagon.
       levothyroxine, bioavail.of other med.prods.poss.affect.  tens.surg., est. intra-abdom. pathology eg.adhes., sev.trauma with   See also MDR page 193.
       SABAX DIANEAL, AI Crit.Care   hypercatabol., sev.cardio respirat.dis., bld. coagulat. defects., rec.  URICON, Mylan (Pty) Ltd
                                     aortic graft replacem., mass. intraperitoneal haematoma, not for IV
       (S3) PERITON.DIALYSIS SOL WITH 1,5% GLUC. L614 [P/S]       See Section 5.4
       Gluc.monohydr.15 g, NaCl 5,6 g, Na lact.5 g, CaCl as dihydr. 260 mg,   inj., safety & effic.in childr.not est., lact.acidos.
                                     Side effects: Dehydrat.with 4,25 gluc.sol.if used excess., peritonit.,
       MgCl as hexahydr. 150 mg / 1000 ml. Approx.osmolarity 364   fluid & electrol.imbal., abdom. pain, bleed., SC infect.around chron.  URISPAS 200, AI Pharm [P/S] &
       mOsmol/L, approx. pH 5,5. Approx.ionic conc.(mmol/L): Na 141, Ca   periton. catheter, catheter block., diffic.fluid remov., ileus, hyper-/hy-  Flavoxate HCl.
       1,8, Mg 0,7, Cl 101, lactate 45.  potens., disequilbrium syndr., allerg. sympts., musc. cramp., alkalosis   Indications: Anti-spasmod.in urologic.disords.
       Indications: Dialysis pts.with low BP                      (S2) TABS. 29/18/0428.
       801305-004: Syst.3:500 ml, R84,95  poss.with Dianeal 2,5 & Dianeal norm Ca sols.  820113-020: 200 mg, 15, R122,65
                                     Special precautions: Eval.risk:benefit ratio in abdom. condits./
       801313-007: Syst.3:1 000 ml, R95,22                        820113-019: 200 mg, 90, R735,98
       801321-018: Syst.3:2 000 ml, R98,17  recent aort.graft replacem.& sev. pulmon.dis., sev.abdom.burns.,   Dosage: Adults incl elderly: 1 tab 3-4xdly at reg. interv. for as
                                     monit.fluid/ electrol. bal./pt.weight, reduc.infect.risk with asept.
       804770-018: Syst.3:2 500 ml, R103,62                       long as reqd.
       705036-002: Syst.3:5 000 ml, R115,61  techniq.dur.& at terminiat.of proced., consid.potent.interact. betw.  Contraindications: Pylor./duod.obstruct., obstruct. intest.les./ileus,
       813680-018: TwinBag: 1 000 ml, R106,55  dialys.treatm.& ther.for other exist.illn., select fluid with low. osmo-  achalas, GI haemorrh., obstruct. low.urin.tract uropath., urin.retent.,
       813931-002: TwinBag: 2 000 ml, R105,90  larity consistent with fluid requirem.to avoid sev.dehydrat./hypovol-  glauc., childr.und. 12 yrs.
                                                  +
       Dosage: Intraperitoneal admin.only using asept. techniq. as per   aem.& minim.prot.loss, addit. of K  chlor.up to conc.of 4 mEq/L indicat.  Side effects: Common: Naus. Uncomm: Eosinophil., leucopen.,
                                                   +
       manufact.lit. Mode of ther.IPD (Intermitt.periton.dialys.) CAPD (Contin.  to prev.sev.hypokalaem.if serum K  lev.norm./low aft.caref.evaluat.of   angioed., CNS effs.incl. drowsin./headache/dizzin./somnol./vertigo,
                                             +
       ambulat. periton.dialys.) or CCPD (Contin.cycl.periton. dialys), freq./  serum & tot.body K lev., vit./ prot.& amino acid replacem.ther.as reqd.,   eye disords.incl.blurr.vis./eye accommodat.disturbs./ incr.ocul.tens.,
       formulat./exchange vol./durat.of dwell & length of dialysis determin.  monit. Mg lev.when using Dianeal 2,5 & norm.Calcium presentat and   tachycard., palpitat., diarrh., dry mouth, dyspeps., dysphag., vomit.,
       by physic. Heat dialysis sol.to 37° C to decr.discomf.& heat loss re-  supplem.when necess./ admin.alt. dialysis sols., avoid meds.that may   urticar., rash, other dermatos., dysur., fatig., hyperpyrex. Rare: Pru-
       sult.in incr. urea clearanc. Addit.may be incompat.& complete info   cause hypermagnesaem.when using Dianeal 2,5 & norm. Calcium   rit., urin.retent. Not known: Hypersens./ anaphylact. react./shock,
       not avail.theref.admin. only if deem.advis.by physic.  presentat, extra-corporeal haemodialys. prefer.when rapid & effic.  confus.state, glauc., constip., jaund., liv.disord., abnorm.hepat. en-
       IPD: Ac.ren.fail.& dialys. maint.of chron.ren.fail. The cycle of   dialys. necess., monit. insul.requirem.in azotem.diab. with norm.Cal-  zym.lev., erythema.
       instillat.,dwell & remov.of dialysis fluid rep.sequentially over 8-36   cium presentat., monit.Na Bicarb. lev. with norm.Calcium presentat  Warnings and special precautions: Susp. glauc., ser./uncontr./ob-
       hrs.as many times/ wk.as determin.by pt.condit.  SABAX HAEMOCARB & SABAX LIQUID BICARBONATE,   struct.low.urin.tract disords., drowsin., safety in porphyr./pregn. & lac-
       Chron.ren.fail.maint.dialys.: Period.dialys.of 3-5 session/wk.for   AI Crit.Care [P/S]  tat. not est., concom.appropr.anti-infect.ther.if urin.infect.evid., diab.
       8-14 hrs./session.            Sabax Haemocarb: Na Cl 172,2 g, KCl 5,5 g, CaCl dihydr. 9,5 g, MgCl   mellit., not for lact.intol indiv., safety & effic.in childr.und.12 yrs.not est.
       CAPD: Maint.dialysis.of chron.ren.fail.as prescrib.  hexahydr. 3,7 g, glacial acet. acid 8,8 g& water for inj.ad 1 000 ml.  Interactions: Enhanc.eff.with other meds.hav. antimuscarin.prop-
       (S3) PERITON.DIALYSIS SOL WITH 2,5% GLUC., S/34/106  Sabax Liquid Bicarbon: Na bicarbon.65,95 g, NaCl 23,53 g & water   ert./inhibit.of meds.-metabolis. enzym.by MAOI’s, absorpt.of other
       Gluc.monohydr.25 g, NaCl 5,38 g, Na lact.4,48 g, CaCl as dihy-  for inj.ad 1 000 ml.  meds.poss.aff. by gastr. motilit.reduct., domperidone/ metoclopro-
       dr.257 mg, MgCl as hexahydr. 50,8 mg/1000 ml. Approx.osmolarity   Final dialysate conc.compris.Sabax Haemocarb & Sabax Liq.Bicar-  mide GI effs.poss. antagonis., Urispas & parasympathomimets.poss.
       396 mOsmol/L, approx.pH 5,5. Approx.ionic conc. (mmol/L): Na 132,   bon.& purif.water mix.in ratio 1:1,83:34 contains as approx.mmol/L:   counteract each other’s effs.
       Ca 1,75, Mg 0,25, Cl 94, lactate 40.  Na 139, Ca 1,75, K 2,0 Mg 0,50, Cl 106,5, bicarbon.35, acet. 4,0.  See also MDR page 118.
       Indications: Periton.dialysis in ac.& chron.ren. fail., sev.water retent.,   Indications: Ac./chron.ren.fail.when non-dialyt. med.ther.judg.in-
       sev.electrol.disturbs., & dialysable intoxicat., when low Mg lev.reqd.  adeq.and suffer.from acetate intol./ vasc.instabil.  UROMAX, Cipla Medpro [P/S]
       857904-019: Syst.3:500 ml, R136,74  (S1) HAEMODIALYSIS CONC., 29/34/0328, 0329  Tamsulosin HCl.
       857912-003: Syst.3:2 000 ml, R101,97  818305-002: Haemocarb, 5 000 ml, R76,26  Indications: Funct.sympts.of benign prostat. hyperplas.(BPH)
       818291-001: Syst.3:2 500 ml, R103,62  833940-007: Liq.Bicarbon., 5 000 ml, R102,07  (S4) MODIF.REL.CAPS, A40/34/0046
       705035-002: Syst.3:5 000 ml, R115,61  Dosage: Supplied in sngl.contain. Dialys.durat./ dialyser use & amnt   710306-001: 0,4 mg, 30, R180,02
       815330-006: TwinBag: 1 000 ml, R106,18  fluid remov.& other details to be specif.by medical practit.in charge   Dosage: Swallow whole in stand./sitt.posit.
       813958-008: TwinBag: 2 000 ml, R107,75  accord. to indiv.requirem.  1 cap.dly.aft.breakf.
       Dosage: Intraperitoneal admin.only using asept. techniq. as per   When ready to use machine connect Haemocarb acid conc.acidif.  Contraindications: Orthostat.hypotens.hist., hepat.insuffic., init.
       manufact.lit. Mode of ther.IPD (Intermitt.periton.dialys.) CAPD (Con-  line 5 mins.bef.connect.Liq. bicarbon. conc.to bicarbon.line. When   ther.prior.to sched.cataract surg., use in females
       tin.ambulat. periton.dialys.) or CCPD freq./formulat./exchange vol./  dialys. complete disconn.bicarbon.line 5 mins.bef. disconn. acid.conc.  Side effects: Hypersens.reacts., angio-oed., CNS effs., intraoperat.
       durat.of dwell & length of dialysis determin. by physic. Heat dialysis   ABBA: Connect acid 1  then bicarbon.bef.treatm. Disconn.bicarbon.1   st  floppy iris syndr., post. hypotens., palpitat., syncope, rhinit., GI dis-
                                              st
       sol.to 37°C to decr. discomf. & heat loss result.in incr.urea clearanc.   then acid aft.treatm.  turbs., abnorm. ejaculat., priapism
       Addit.may be incompat.theref. consult pharmacist. 1 000-2 000 USP   Side effects: Hypotens., hypovolaem.shock if remov.of ultrafiltr.  Special precautions: Thorough examin.bef.init. ther.to excl.other
       units hepar.may be add.per litre sol.to prev.cathet.block.  exceeds recomm.rate,.  condit.caus.same sympt., determ. PSA bef.& reg.aft., intraoperat.flop-
       Usual dos: Adults: 2 L/hr with tot.dialys.period not exceed.36 hrs.   Special precautions: Bact.growth in conc.liq. bicarbon.sols., high   py iris syndr.report.dur.cataract surg incr.risk of procedur. complicat.
       Childr: 0,4-1 L/hr.with max. durat. of 36 hrs.  BP, chron.uraem.  dur.cataract surg., pre-op assessm.of cataract surg.pts.
       (S3) NORMAL Ca WITH 1,5% GLUC.PERITON. DIALYSIS            Drug interactions: Cimetidine incr.plasma lev., furosem.decr.plasma
       SOL, 29/34/0325               SILODYX, Litha               lev., diclofen.& warfar.may incr. eliminat.rate, other alpha 1-adreno-
       Gluc.monohydr.15,0 g, NaCl 5,38 g, Na lact.4,48 g, CaCl as dihydr.   Silodosin  cept.block. exacerb.hypotens.eff.
       0,183 g, MgCl as hexahydr. 0,0508 g /1000 ml. Approx.osmolarity 344     Indications: Benign prostat.hyperplas.  XATRAL XL, Sanofi-Aventis (Pty) Ltd
       mOsmol/L, approx.pH 5,2. Approx.ionic conc. (mmol/L): Na 132, Ca   (S4) HARD GEL CAPS, 45/32.2/0118, 0119  See Section 7.3.2
       1,25, Mg 0,25, Cl 95, lactate 40.  719881-001: 4 mg, 30, R366,11
       838918-018: 1000 ml, R103,42.  719882-001: 8 mg, 30, R366,11
       857920-006: 2 000 ml, R103,44  Dosage: Admin.with food at pref. same time dly. Swallow whole
       703801-001: 2 500 ml, R104,95  without break/chew. Recomm.dos: One 8 mg cap.dly. Start.dos.of   17   GENITAL SYSTEM
       710449-001: Syst.3:5 000ml, R140,22.  4 mg once dly recomm. in pts.with mod.ren.impairm.which may be
       (S3) NORMAL Ca WITH 2,5% GLUC. PERITON.DIALYSIS   incr.to 8 mg once dly aft.one wk.depend.on pt. respons.
       SOL 29/34/0326                Contraindications: No relev.indic.for use in childr. & adolesc.,
       Gluc.monohydr.25,0 g, NaCl 5,38 g, Na lact.4,48 g, CaCl as dihydr.   concom.potent inhibit.such as ketoconazole/ itraconazole/ritonavir  17.1  Contraceptives
       0,183 g, MgCl as hexahydr. 0,0508 g/1000 ml. Approx.osmolarity 395     not recomm., concom. other α-adrenorecept.antagon.not recomm.
       mOsmol/L, approx.pH 5,2. Approx.ionic conc. (mmol/L): Na 132, Ca   Side effects: Ejaculat.disords., erect.dysfunct., decr.libido, dizzin., syncope,
       1,25, Mg 0,25, Cl 95, lactate 40.  orthostat.hypotens., nas.congest., GI disturbs., inoperat.floppy iris syndr.  17.1.1   Hormonal (including
       838926-029: 1 000 ml, R101,63.  Warnings and special precautions: Not recomm.in sev.ren./
       846503-018: 2 000 ml, R101,96.  hepat.impairm./orthostat. hypotens., not recomm.in pts.for whom   oral)
       703794-001: 2 500 ml, R105,19  cataract surg.is sched., eye surg.to cons.if pts.sched.for cataract
       710451-001: Syst.3:5 000ml, R132,53  surg.present./prev.treat.with Silodyx, rule out prostate Ca bef.init.  CONTRA INDICATIONS: Known or suspected carcinoma of the
       (S3) NORMAL Ca WITH 4,25% GLUC. PERITON.DIALYSIS   ther., digit.rect.exam./PSA advis.bef.& at reg. interv.dur.ther., pt.to be   breast or endometrium; cerebrovascular insufficiency, coronary
       SOL 29/34/0327                inform. bef.init.ther.that ejaculat.with reduc./no semen poss. occur   artery disease, valvular heart disease; disturbance of lipometabolism;
       Gluc.monohydr.42,5 g, NaCl 5,38 g, Na lact.4,48 g, Ca Cl as dihydr.   & tempor.affect.male fertil., monit.pts. with concom.PDE-5 inhibit./  cholestatic jaundice of pregnancy or jaundice with prior contracep-
       0,183 g, MgCl as hexahydr. 0,0508 g/1000 ml. Approx.osmolarity   start.antihypertens. ther.  tive pill use; history of herpes of pregnancy; known or suspected
       383 mOsmol/L, approx.pH 5,2. Approx.ionic conc. (mmol/L): Na 132,   Drug interactions: Plasma conc.poss.affect.by subst. that inhib./  oestrogen-dependent neoplasms; lactation; otosclerosis with de-
       Ca 1,25, Mg 0,25, Cl 95, lactate 40.  induc. CYP3A4/alcoh. dehydrogenase /UGT2B7/P-glycoprot., incr.  terioration during pregnancy; patients with known or suspected
       857890-018: 1 000 ml, R102,73.  plasma conc./ expos.with concom.potent CYP3A4 inhib., incr. AUC   pregnancy; previous or existing benign/malignant liver tumours;
       857939-009: 2 000 ml, R102,17.  with mod.potent CYP3A4 inhib.  previous or existing thrombophlebitis/thromboembolic disorders;
       Indications: Periton.dialys.in ac.& chron.ren. fail. being maint.on   known thrombophilic conditions; relative contraindications include
       Continuous Ambulatory Peritoneal Dialysis (CAPD) or Intermittent   TAMSUL, (Aspen Pharmacare: Pharma) Pharmacare [P/S] &  history of diabetes mellitus, epilepsy, asthma, hypertension, depres-
       Peritoneal Dialysis (IPD) or Continuous Cyclic Peritoneal Dialysis   Tamsulosin HCl.  sion, porphyria, states of fluid retention occurring; severe diabetes
       (CCPD) when nondialyt. medic.ther.inadeq.  Indications: Funct.sympts.of benign prostat. hyperplas.(BPH)  with vascular involvement; acute or chronic hepatocellular disease
       Dosage: Intraperitoneal admin.only using asept. techniq. as per   (S4) SR CAPS, A40/34/0316  with abnormal liver function; severe migraine; sickle cell anaemia;
       manufact.lit. Mode of ther.IPD (Intermitt.periton.dialys.) CAPD (Con-  706713-001: 0,4 mg, 30, R244,52  undiagnosed abnormal vaginal bleeding.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page251.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page247.html">247</a>&nbsp;&nbsp;&nbsp;<a href="page248.html">248</a>&nbsp;&nbsp;&nbsp;<a href="page249.html">249</a>&nbsp;&nbsp;&nbsp;<a href="page250.html">250</a>&nbsp;&nbsp;&nbsp;<a href="page251.html">251</a>&nbsp;&nbsp;&nbsp;<a href="page252.html">252</a>&nbsp;&nbsp;&nbsp;<a href="page253.html">253</a>&nbsp;&nbsp;&nbsp;<a href="page254.html">254</a>&nbsp;&nbsp;&nbsp;<a href="page255.html">255</a>&nbsp;&nbsp;&nbsp;<a href="page256.html">256</a>&nbsp;&nbsp;&nbsp;<a href="page257.html">257</a>
             </td>
             <td width="35%"><a href="page253.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page253.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
